Patients with certain GLP1R or GIPR variants may experience more pronounced or earlier-onset anxiety symptoms, not because the medication is unsafe, but because their baseline receptor sensitivity differs
While some reports suggest that the medication has the potential to ameliorate fibrosis and reduce liver fat, others have raised concerns about exacerbation of underlying liver disease
Clinical trials have demonstrated that Melanotan I may increase the skins tolerance to UV exposure, significantly improving the quality of life for patients with EPP
While the indirect effects through weight loss and metabolic improvement are supported by current research, direct effects on the hormonal axis require further investigation
Metformin and acid-reducing drugs (e.g., omeprazole) can lower B12 absorption over time
Beyond butyrate: microbial fiber metabolism supporting colonic epithelial homeostasis